In 2018, LifeMark Partners, Inc. became the first-ever IMO to offer cancer genomic profiling to more than 2 million Americans as a part of its life insurance policies. Available exclusively through LifeMark Partners affiliated BGAs, this first-of-its kind offer allows BGAs to initially provide 250,000 Americans who purchase new life insurance policies with instant complimentary access for one year to Wamberg Genomic Advisors' Cancer GuardianTM program. After the first year, it is then priced at less than $20 per month from that point on, and family members can also be included with coverage.
This program is changing lives by making the genetic profiles of an individual's cancer more accessible, leading to a more accurate diagnosis and personalized treatment plans.
"What LifeMark is doing is unprecedented and invaluable. An individual's cancer genomic profile, first and foremost, can be instrumental in helping patients beat cancer by helping physicians create powerful, personalized care paths," said Thomas Wamberg, president and CEO of Wamberg Genomic Advisors. "LifeMark and its BGAs are also part of a much greater societal good. As more people with cancer receive comprehensive genomic profiling tests, the more scientific data we have to move towards a cure for cancer."
For more information, read the press release announcing the launch of this program or contact our office today to learn how you can deliver this powerful new level of value to your agents and the families they serve in a time they need it most.